Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanthida Huang

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Antimicrobial Agents|November 11, 2009
Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureusVanthida Huang, Chrissy M Cheung, Glenn W Kaatz, et al.
BMC Infectious Diseases|October 27, 2011
Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureusYoriko Harigaya, Dung Ngo, Alan J Lesse, et al.
Microbiology Spectrum|June 15, 2022
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood IsolatesJaclyn A Cusumano, Ruhma Khan, Zeel Shah, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKyle C Molina, Taylor Morrisette, Matthew A Miller, et al.
Journal of Intensive Care Medicine|February 12, 2019
The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or CefepimeKyle C Molina, Jeffrey F Barletta, Scott T Hall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 30, 2017
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes studySamia Arshad, Vanthida Huang, Pamela Hartman, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2021
Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?Madeline M Johnston, Vanthida Huang, Scott T Hall, et al.
Surgical Infections|July 24, 2019
Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal ClearanceKyle C Molina, Scott T Hall, Jeffrey F Barletta, et al.
International Journal of Antimicrobial Agents|February 24, 2009
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapyFred C Tenover, Scott W Sinner, Robert E Segal, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infectionsAdenike Shoyinka, Daniela Moreno, Samia Arshad, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Antimicrobial Agents|November 11, 2009
Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureusVanthida Huang, Chrissy M Cheung, Glenn W Kaatz, et al.
BMC Infectious Diseases|October 27, 2011
Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureusYoriko Harigaya, Dung Ngo, Alan J Lesse, et al.
Microbiology Spectrum|June 15, 2022
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood IsolatesJaclyn A Cusumano, Ruhma Khan, Zeel Shah, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKyle C Molina, Taylor Morrisette, Matthew A Miller, et al.
Journal of Intensive Care Medicine|February 12, 2019
The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or CefepimeKyle C Molina, Jeffrey F Barletta, Scott T Hall, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 30, 2017
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes studySamia Arshad, Vanthida Huang, Pamela Hartman, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2021
Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?Madeline M Johnston, Vanthida Huang, Scott T Hall, et al.
Surgical Infections|July 24, 2019
Utilization of Augmented Renal Clearance in Trauma Intensive Care Scoring System to Improve Vancomycin Dosing in Trauma Patients at Risk for Augmented Renal ClearanceKyle C Molina, Scott T Hall, Jeffrey F Barletta, et al.
International Journal of Antimicrobial Agents|February 24, 2009
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapyFred C Tenover, Scott W Sinner, Robert E Segal, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infectionsAdenike Shoyinka, Daniela Moreno, Samia Arshad, et al.
Pageof 3